212 related articles for article (PubMed ID: 10520234)
1. Retinoblastoma with low risk for extraocular relapse.
Chantada GL; de Dávila MT; Fandiño A; Manzitti J; Raslawski E; Casak S; Schvartzman E
Ophthalmic Genet; 1999 Sep; 20(3):133-40. PubMed ID: 10520234
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for extraocular relapse following enucleation after failure of chemoreduction in retinoblastoma.
Chantada GL; Dunkel IJ; Antoneli CB; de Dávila MT; Arias V; Beaverson K; Fandiño AC; Chojniak M; Abramson DH
Pediatr Blood Cancer; 2007 Sep; 49(3):256-60. PubMed ID: 17029248
[TBL] [Abstract][Full Text] [Related]
3. Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.
Zhao J; Dimaras H; Massey C; Xu X; Huang D; Li B; Chan HS; Gallie BL
J Clin Oncol; 2011 Mar; 29(7):845-51. PubMed ID: 21282531
[TBL] [Abstract][Full Text] [Related]
4. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion.
Chantada GL; Casco F; Fandiño AC; Galli S; Manzitti J; Scopinaro M; Schvartzman E; de Dávila MT
Ophthalmology; 2007 Nov; 114(11):2083-9. PubMed ID: 17459482
[TBL] [Abstract][Full Text] [Related]
5. Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children's Oncology Group Study.
Chévez-Barrios P; Eagle RC; Krailo M; Piao J; Albert DM; Gao Y; Vemuganti G; Ali MJ; Khetan V; Honavar SG; O'Brien J; Leahey AM; Matthay K; Meadows A; Chintagumpala M
J Clin Oncol; 2019 Nov; 37(31):2883-2891. PubMed ID: 31539297
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of chemoprophylaxis in patients with unilateral retinoblastoma with high-risk features on histopathologic examination.
Uusitalo MS; Van Quill KR; Scott IU; Matthay KK; Murray TG; O'Brien JM
Arch Ophthalmol; 2001 Jan; 119(1):41-8. PubMed ID: 11146725
[TBL] [Abstract][Full Text] [Related]
7. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
[TBL] [Abstract][Full Text] [Related]
8. Comparison of staging systems for extraocular retinoblastoma: analysis of 533 patients.
Chantada GL; Sampor C; Bosaleh A; Solernou V; Fandiño A; de Dávila MT
JAMA Ophthalmol; 2013 Sep; 131(9):1127-34. PubMed ID: 23787805
[TBL] [Abstract][Full Text] [Related]
9. Histopathologic risk factors in retinoblastoma: a retrospective study of 172 patients treated in a single institution.
Khelfaoui F; Validire P; Auperin A; Quintana E; Michon J; Pacquement H; Desjardins L; Asselain B; Schlienger P; Vielh P
Cancer; 1996 Mar; 77(6):1206-13. PubMed ID: 8635145
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.
Brennan RC; Qaddoumi I; Billups CA; Free TL; Haik BG; Rodriguez-Galindo C; Wilson MW
Br J Ophthalmol; 2015 Oct; 99(10):1366-71. PubMed ID: 25873648
[TBL] [Abstract][Full Text] [Related]
11. Enucleated globes with advanced retinoblastoma: correlation of histopathological features and reclassification of tumors according to the 8th edition of the American Joint Committee on Cancer (AJCC).
Alkatan HM; AlQahtani FS; Maktabi AM
Int Ophthalmol; 2020 Jul; 40(7):1739-1747. PubMed ID: 32193778
[TBL] [Abstract][Full Text] [Related]
12. Retinoblastoma patients with high risk ocular pathological features: who needs adjuvant therapy?
Chantada GL; Dunkel IJ; de Dávila MT; Abramson DH
Br J Ophthalmol; 2004 Aug; 88(8):1069-73. PubMed ID: 15258027
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.
Dikkaya F; Sarıcı AM; Erbek F; Celkan T; Mangan MS; Aydın Ö; Demirkesen C; Pazarlı H
Int Ophthalmol; 2018 Feb; 38(1):151-156. PubMed ID: 28058667
[TBL] [Abstract][Full Text] [Related]
14. Orbital recurrence of retinoblastoma following enucleation.
Kim JW; Kathpalia V; Dunkel IJ; Wong RK; Riedel E; Abramson DH
Br J Ophthalmol; 2009 Apr; 93(4):463-7. PubMed ID: 18757474
[TBL] [Abstract][Full Text] [Related]
15. Anterior segment invasion in retinoblastoma: is it a risk factor for extraocular relapse?
Baroni LV; Sampor C; Fandiño A; Solernou V; Demirdjian G; de Davila MT; Chantada GL
J Pediatr Hematol Oncol; 2014 Nov; 36(8):e509-12. PubMed ID: 24732059
[TBL] [Abstract][Full Text] [Related]
16. Outcome of children with retinoblastoma and isolated choroidal invasion.
Bosaleh A; Sampor C; Solernou V; Fandiño A; Domínguez J; de Dávila MT; Chantada GL
Arch Ophthalmol; 2012 Jun; 130(6):724-9. PubMed ID: 22801832
[TBL] [Abstract][Full Text] [Related]
17. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
[TBL] [Abstract][Full Text] [Related]
18. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors.
Chong EM; Coffee RE; Chintagumpala M; Hurwitz RL; Hurwitz MY; Chévez-Barrios P
Arch Pathol Lab Med; 2006 Nov; 130(11):1669-72. PubMed ID: 17076529
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation the risk of optic nerve invasion associated with optic nerve obscuration in advanced retinoblastoma].
Deng X; Cheng Y; Zhu XM; Linghu DD; Zhao MW; Liang JH
Zhonghua Yan Ke Za Zhi; 2020 Sep; 56(9):681-687. PubMed ID: 32907301
[No Abstract] [Full Text] [Related]
20. Postenucleation adjuvant therapy in high-risk retinoblastoma.
Honavar SG; Singh AD; Shields CL; Meadows AT; Demirci H; Cater J; Shields JA
Arch Ophthalmol; 2002 Jul; 120(7):923-31. PubMed ID: 12096963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
